Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anaptysbio Inc

18.51
-0.7800-4.04%
Post-market: 18.50-0.0100-0.05%19:54 EDT
Volume:853.32K
Turnover:15.87M
Market Cap:567.64M
PE:-3.62
High:19.36
Open:18.67
Low:18.06
Close:19.29
Loading ...

AnaptysBio Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
07 Nov 2024

Stock Track | AnaptysBio Soars in Pre-Market on Upbeat Earnings Outlook

Stock Track
·
06 Nov 2024

AnaptysBio Inc expected to post a loss of $1.59 a share - Earnings Preview

Reuters
·
06 Nov 2024

AnaptysBio Inc : H.c. Wainwright Cuts Target Price to $52 From $55

THOMSON REUTERS
·
06 Nov 2024

AnaptysBio price target lowered to $52 from $55 at H.C. Wainwright

TIPRANKS
·
06 Nov 2024

U.S. RESEARCH ROUNDUP-Apollo, Booking Holdings, Portillos

Reuters
·
06 Nov 2024

AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
06 Nov 2024

AnaptysBio Q3 EPS $(1.14) Beats $(1.65) Estimate, Sales $30.02M Beat $6.87M Estimate

Benzinga
·
06 Nov 2024

AnaptysBio Inc: Cash and Investments of $458.0 Mln as of September 30, 2024 and Reiterating Cash Runway Through Year-End 2026

THOMSON REUTERS
·
06 Nov 2024

AnaptysBio Inc: Qtrly Shr Loss $1.14

THOMSON REUTERS
·
06 Nov 2024

Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

THOMSON REUTERS
·
06 Nov 2024

AnaptysBio Q3 Collaboration Revenue USD 30.017 Million

THOMSON REUTERS
·
06 Nov 2024

AnaptysBio Q3 Operating Expenses USD 52.774 Million

THOMSON REUTERS
·
06 Nov 2024

AnaptysBio Q3 Net Income USD -32.851 Million

THOMSON REUTERS
·
06 Nov 2024

Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire
·
06 Nov 2024

Anaptys Announces Participation in November and December Investor Conferences

GlobeNewswire
·
06 Nov 2024

AnaptysBio (ANAB) Gets a Buy from BTIG

TIPRANKS
·
05 Nov 2024

AnaptysBio (ANAB) Gets a Hold from Truist Financial

TIPRANKS
·
04 Nov 2024

AnaptysBio Price Target Maintained With a $55.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Oct 2024

UBS Adjusts Price Target on AnaptysBio to $33 From $23, Maintains Neutral Rating

MT Newswires Live
·
30 Oct 2024